Biblio

Export 3139 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
S. S. Buss, Padmanabhan, J., Saxena, S., Pascual-Leone, A., and Fried, P. J., “Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1301-1312, 2018.
J. Neugroschl, Sewell, M., De La Fuente, A., Umpierre, M., Luo, X., and Sano, M., “Attitudes and Perceptions of Research in Aging and Dementia in an Urban Minority Population.”, J Alzheimers Dis, vol. 53, no. 1, pp. 69-72, 2016.
J. D. Grill, Holbrook, A., Pierce, A., Hoang, D., and Gillen, D. L., “Attitudes toward Potential Participant Registries.”, J Alzheimers Dis, vol. 56, no. 3, pp. 939-946, 2017.
V. I. Dobromyslin and Megherbi, D. B., “Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 87, no. 2, pp. 583-594, 2022.
S. Müller, Mychajliw, C., Reichert, C., Melcher, T., and Leyhe, T., “Autobiographical Memory Performance in Alzheimer's Disease Depends on Retrieval Frequency.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1215-25, 2016.
M. Kobayashi, Yamada, Y., Shinkawa, K., Nemoto, M., Nemoto, K., and Arai, T., “Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1075-1089, 2022.
L. Xie, Shinohara, R. T., Ittyerah, R., Kuijf, H. J., Pluta, J. B., Blom, K., Kooistra, M., Reijmer, Y. D., Koek, H. L., Zwanenburg, J. J. M., Wang, H., Luijten, P. R., Geerlings, M. I., Das, S. R., Biessels, G. Jan, Wolk, D. A., Yushkevich, P. A., and Wisse, L. E. M., “Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?”, J Alzheimers Dis, vol. 63, no. 1, pp. 217-225, 2018.
C. Themistocleous, Ficek, B., Webster, K., Ouden, D. - Bden, Hillis, A. E., and Tsapkini, K., “Automatic Subtyping of Individuals with Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1185-1194, 2021.
C. Y. Santos, Machan, J. T., Wu, W. - C., and Snyder, P. J., “Autonomic Cardiac Function in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1057-1065, 2017.
L. Ho, Legere, M., Li, T., Levine, S., Hao, K., Valcarcel, B., and Pasinetti, G. M., “Autonomic Nervous System Dysfunctions as a Basis for a Predictive Model of Risk of Neurological Disorders in Subjects with Prior History of Traumatic Brain Injury: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 305-315, 2017.
Y. Yin, Zhao, Y., Han, S., Zhang, N., Chen, H., and Wang, X., “Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.”, J Alzheimers Dis, vol. 59, no. 3, pp. 851-869, 2017.
K. E. McLimans and Willette, A. A., “Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.”, J Alzheimers Dis, vol. 56, no. 1, pp. 403-413, 2017.
A. V. Ivachtchenko, Lavrovsky, Y., and Okun, I., “AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.”, J Alzheimers Dis, vol. 53, no. 2, pp. 583-620, 2016.
A. V. Ivachtchenko, Okun, I., Aladinskiy, V., Ivanenkov, Y., Koryakova, A., Karapetyan, R., Mitkin, O., Salimov, R., and Ivashchenko, A., “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
T. Daly, Mastroleo, I., and Migliaccio, R., “Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention.”, J Alzheimers Dis, vol. 90, no. 3, pp. 989-992, 2022.
A. Tsugawa, Sakurai, S., Inagawa, Y., Hirose, D., Kaneko, Y., Ogawa, Y., Serisawa, S., Takenoshita, N., Sakurai, H., Kanetaka, H., Hirao, K., and Shimizu, S., “Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 539-541, 2020.
S. Eketjäll, Janson, J., Kaspersson, K., Bogstedt, A., Jeppsson, F., Fälting, J., Haeberlein, S. Budd, Kugler, A. R., Alexander, R. C., and Cebers, G., “AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1109-23, 2016.
G. Cebers, Alexander, R. C., Haeberlein, S. Budd, Han, D., Goldwater, R., Ereshefsky, L., Olsson, T., Ye, N., Rosen, L., Russell, M., Maltby, J., Eketjäll, S., and Kugler, A. R., “AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1039-1053, 2017.
I. Koychev, Galna, B., Zetterberg, H., Lawson, J., Zamboni, G., Ridha, B. H., Rowe, J. B., Thomas, A., Howard, R., Malhotra, P., Ritchie, C., Lovestone, S., and Rochester, L., “Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1377-1383, 2018.
L. Ordoñez-Gutierrez, Fernandez-Perez, I., Herrera, J. Luis, Anton, M., Benito-Cuesta, I., and Wandosell, F., “AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging.”, J Alzheimers Dis, vol. 54, no. 2, pp. 645-56, 2016.
H. Bielarczyk, Jankowska-Kulawy, A., Hofling, C., Ronowska, A., Gul-Hinc, S., Rossner, S., Schliebs, R., Pawelczyk, T., and Szutowicz, A., “AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
B
X. Gong, Shi, L., Wu, Y., Luo, Y., and Kwok, T., “B Vitamin Supplementation Slows Cognitive Decline in Mild Cognitive Impairment Patients with Frontal Lobe Atrophy.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1453-1461, 2022.
H. Jakubowski, Zioła-Frankowska, A., Frankowski, M., Perła-Kaján, J., Refsum, H., de Jager, C. A., and A Smith, D., “B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 3, pp. 1039-1055, 2021.
M. Timmers, Barão, S., Van Broeck, B., Tesseur, I., Slemmon, J., de Waepenaert, K., Bogert, J., Shaw, L. M., Engelborghs, S., Moechars, D., Mercken, M., Van Nueten, L., Tritsmans, L., De Strooper, B., and Streffer, J. Rolf, “BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1437-1449, 2017.
Y. Jie Yeap, Kandiah, N., Nizetic, D., and Lim, K. - L., “BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S159-S171, 2023.

Pages